three new approaches cancer treatment giving promising results early clinical tests oncology conference london told yesterday all three result collaborative research involving scotia pharmaceuticals ukcanadian drug company university medical centres uk overseas potentially farreaching treatment tumourkilling drug ef13 scotia described magic bullet could destroy cancer cells without harming normal tissues preliminary clinical trials indicate drug may double survival time patients latestage pancreatic breast cancers the doctors involved however wary making extravagant claims still experimental drug ef13 seems important therapeutic effects without harming patients said mr ken fearon edinburgh universitys department surgery it really different anything else available dr david horrobin scotia chief executive said ef13 developed potent cell killer cancer drugs free toxic side effects make conventional chemotherapy unpleasant it similar chemically evening primrose oil recently main source income company the second new drug ef27 reduces harmful effects radiotherapy trials radiobiology research group oxfords churchill hospital show drug protect normal tissue radiation damage enhancing damage caused cancer cells the third drug ef9 lightactivated chemical designed improve form cancer treatment known photodynamic therapy ef9 destroys cancer cells tumour illuminated laser if treatments continue show promise could available commercially within three four years